ResMed company profile

RMD · NYSE · USD

Compare ResMed
$237.85Change from previous close: −0.14%Absolute change: −$0.34

Close · November 17, 2026

Company profile

ResMed has 11,370 employees and is headquartered in San Diego, United States.

Founded in 1989 and based in San Diego, California, ResMed develops digital health and cloud-connected medical devices, with a focus on sleep apnea. Its sleep recorders, such as ApneaLink Air and NightOwl, are used in sleep clinics, hospitals and at home, while AirView and the myAir application allow remote monitoring of device settings and patient therapy. Through its Residential Care Software segment, the company supplies software to home medical equipment and pharmacy providers, home health and hospice agencies, and skilled nursing and senior living operators, including Brightree, HEALTHCAREfirst, MatrixCare and MEDIFOX DAN. It serves customers in the United States and internationally.

In the fiscal year ended June 2026, ResMed reported revenue of 5.7 billion US dollars, up 9.9% from the previous year, and net profit of 1.5 billion US dollars. The United States accounted for 63% of revenue and non-US markets for 37%. The company employed 11,370 people, and its headquarters are in San Diego.

Company facts

Industry
Medical Instruments & Supplies
Headquarters
9001 Spectrum Center Boulevard, 92123, San Diego
Employees
11,370
Chief executive
Michael Farrell
Founded
1989
Fiscal year
July - June
Listing
RMD · NYSE
Indices
S&P 500
Currency
USD
ISIN
US7611521078
Website
resmed.com

ResMed and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
ResMedRMDUnited States$33.5B11,37034.0%21.8
West Pharmaceutical ServicesWSTUnited States$29.1B10,00022.9%46.9
MedlineMDLNUnited States$42.57B45,0005.0%40.2
Becton, DickinsonBDXUnited States$58.96B60,00015.7%42.8
SolventumSOLVUnited States$15.07B20,5845.9%99.6
Baxter InternationalBAXUnited States$13.41B37,5007.6%—

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare ResMed with its competitors